Maigen Bethea, Francis Marion University
Jessica Boni, Emory University
Shara Legg, University of Alabama at Birmingham
Ashley Richey, Auburn University
Kevin Stoltz, John Carroll University
Crystal Taylor, University of Alabama at Birmingham
Rachel Underwood, University of Arizona
Hala Zein-Sabatto, Vanderbilt University
Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education.
About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.
About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.
Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
UAB marks the grand opening of Alabama’s largest nuclear magnetic resonance facility.The University of Alabama at Birmingham unveiled the state’s largest and most advanced nuclear magnetic resonance (NMR) facility this morning at a grand-opening event and tour. The laboratory is another world-class example of the interdisciplinary emphasis that is a hallmark of UAB, accelerating the university’s reputation as a leader in medical research. The new 1,600-square-foot Central Alabama High-Field Nuclear Magnetic Resonance Facility is housed in a newly renovated laboratory in the Department of Chemistry. The approximately $3.5 million project is the result of a partnership between the National Center for Research Resources, National Cancer Institute, UAB Health Services Foundation, and the offices of the vice president for Research and Economic Development and the deans of the School of Medicine and College of Arts and Sciences. The facility provides state-of-the-art sensitivity and resolution for biomedical research and drug discovery for treatment...
UAB adds Biomedical Sciences as a major; will train professionals in processes and methods for diagnosing, analyzing and treating diseases.Written by Kevin Storr The Alabama Commission on Higher Education (ACHE) and the University of Alabama System Board of Trustees approved the addition of a Bachelor of Science degree in Biomedical Sciences at the University of Alabama at Birmingham (UAB). This new program, housed in the UAB School of Health Professions, leverages the strengths and expertise from faculty across campus to emphasize the study of life processes in the context of human health and disease risk, diagnosis, management and treatment. This unique curriculum is human-based and clinically focused, and it will prepare students for health-related graduate and professional programs or for entry into one of the fastest growing occupational sectors. The U.S. Bureau of Labor Statistics estimates healthcare practitioners and technical occupations, combined with healthcare support occupations, will add approximately 3.4 million jobs from...
Birmingham native Tipton joined Southern Research in 2004. Southern Research Institute today announced that Arthur J. Tipton, Ph.D., will serve as Southern Research president and CEO effective July 8, 2013. Arthur J. Tipton, Ph.D.Tipton will report to the Southern Research Institute Board of Directors chaired by University of Alabama at Birmingham (UAB) President Ray L. Watts. Southern Research is an incorporated affiliate of UAB. “The Board is extremely pleased that Dr. Tipton will lead Southern Research, and I look forward to working with him,” Watts said. “This is a critical time for research, with both opportunities and challenges, and his experience and strategic vision are ideal to grow the organization's portfolio of contract research in biomedical science, drug discovery and advanced technology/engineering.” Tipton was Evonik’s (formerly SurModics and Brookwood Pharmaceuticals) senior vice president and general manager. During his career, he has helped lead the growth of three pharmaceutical/biotech companies and launched four commercial products....